Peers & Perspectives in Oncology
December II, 2023
Volume: 1
Issue: 11
December I, 2023
Volume: 1
Issue: 10
November II, 2023
Volume: 1
Issue: 9
November I, 2023
Volume: 1
Issue: 8
October II 2023
Volume: 1
Issue: 7
October I 2023
Volume: 1
Issue: 6
September 2023
Volume: 1
Issue: 5
August 2023
Volume: 1
Issue: 4
July II 2023
Volume: 1
Issue: 3
July I 2023
Volume: 1
Issue: 2
June 2023
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5